Latest / Science News Today | 2 Min News | The Daily News Now!
New Drug Doubles Survival for Pancreatic Cancer | Science News
U.S. just approved a game-changing drug for pancreatic cancer—daraxonrasib, a two-pill-a-day treatment that’s doubling survival times for metastatic patients who’ve failed chemo. In trials, median survival jumped from 6.5 to over 13 months, with some living years—a rare win in a disease with a dismal five-year survival rate. This breakthrough offers new hope when all else fails, and while pricing is pending, the impact on lives is already undeniable. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.